Is ImmuCell Corporation overvalued?

ImmuCell Corporation (ICCC) — key valuation metrics and fundamentals.

No verdict

Price

$10.16

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$91.6M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares ICCC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.

Related stocks